MLchartDataset catalogue

PF-00299804

Term · Oncology and biomedicine · MLC-T-ONC-006565

A drug used to treat non-small cell lung cancer that has spread, has not already been treated, and has certain mutations (changes) in the EGFR gene. It is also being studied in the treatment of other types of cancer. PF-00299804 blocks certain proteins, which may help keep cancer cells from growing and may kill them. It is a type of tyrosine kinase inhibitor. Also called dacomitinib and Vizimpro.

Table 1. Record
IdentifierMLC-T-ONC-006565
FieldOncology and biomedicine
Expansionsdacomitinib; Vizimpro
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-006565",
  "term": "PF-00299804",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat non-small cell lung cancer that has spread, has not already been treated, and has certain mutations (changes) in the EGFR gene. It is also being studied in the treatment of other types of cancer. PF-00299804 blocks certain proteins, which may help keep cancer cells from growing and may kill them. It is a type of tyrosine kinase inhibitor. Also called dacomitinib and Vizimpro.",
  "expansions": [
    "dacomitinib",
    "Vizimpro"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/pf-00299804/"
}

Record 13,054 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.